ArticleEuropean journal of clinical pharmacology2022

Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects.

Katsuyuki Murase et al.PubMed ↗Publisher ↗

No numbers read from the abstract.